Study Links Common Painkillers to Antibiotic Resistance
A recent study has raised some eyebrows regarding two widely-used over-the-counter pain relievers in the U.S.—ibuprofen (commonly known as Advil) and acetaminophen (often referred to as Tylenol). Surprisingly, these everyday medications may contribute to a pressing global health issue.
Researchers from the University of South Australia have discovered that these common painkillers can encourage the development of superbugs, ultimately exacerbating antibiotic resistance. The team experimented with E. coli bacteria and the antibiotic ciprofloxacin, frequently prescribed for urinary tract infections.
They found that both ibuprofen and acetaminophen, whether used alone or together, promote antibiotic resistance. Dr. Mark Siegel, a senior medical analyst, pointed out the well-known link between excessive antibiotic use and resistance, emphasizing the study’s unsettling implications.
Past research has also indicated that nonsteroidal anti-inflammatory drugs (NSAIDs) and antidepressants could foster antibiotic resistance. In this new study, exposure of E. coli to ciprofloxacin alongside ibuprofen and acetaminophen notably increased the bacteria’s genetic mutations. These genetic changes rendered the E. coli strain much more resistant not just to ciprofloxacin but to other antibiotics as well.
Professor Rietie Venter, who led the study, remarked that antibiotic resistance now extends beyond just antibiotics themselves, highlighting the potential impact of various medications.
The findings particularly concern environments like elderly care facilities, where patients often receive a mix of different medications, including painkillers and other drugs analyzed in this study. This diversity potentially escalates the risk of resistant superbugs in such settings.
The World Health Organization (WHO) has identified antibiotic resistance as a significant global health threat. In 2019, drug-resistant bacteria led to approximately 1.27 million deaths and were linked to nearly 5 million more. Projections indicate that, if trends continue, the death toll from antibiotic resistance could climb to around 40 million in the next 25 years.
While the study underscores these alarming findings, Professor Venter suggests that rather than discontinuing the use of these painkillers, the focus should shift toward educating people about their interactions with antibiotics. In high-risk environments, healthcare providers might want to rethink medication regimens and explore safer options.
To combat antibiotic resistance, experts encourage minimizing unnecessary prescriptions and completing treatment courses whenever prescribed. Responses from the manufacturers of Tylenol and Advil have yet to be released.
